RxDoctor Payments Data

Colleen Keegan, DO

Dermatology · Naperville, ILNPI 1497937106

Payments from drug & device makers

What this record shows

Almost everything reported here is food and beverage — 99.0% of the total across 42 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. 14 manufacturers reported payments, led by Regeneron at 35.4% of the total. Reporting peaked in 2019 at $1,203 and has fallen 98.7% since, to $15 in 2023. That places this record below the midpoint for dermatology clinicians in IL, where the typical reported total is $1,774.

$1,488in general payments, 2019–2025

Across 42 payments — averaging $35.43 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Regeneron$526
  • AbbVie$199
  • Sun Pharmaceutical Industries Inc.$158
  • Prugen, Inc. Pharmaceuticals$118
  • Pfizer$87
  • Galderma Laboratories, L.p.$85
  • plus $315 from 8 others

What the payments were for

  • Food & beverage$1,47399%
  • Education$151%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
22
23

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$1,488 in reported general payments places this provider in the 45th percentile of 606 dermatology providers in Illinois.

See all dermatology providers in Illinois →

Medicare billing

Part B allowed, 2024
$104,720
Medicare patients
310
Services billed
1,396

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Humira(Cf) PenAdalimumab34$354,053
Dupixent PenDupilumab31$117,699
Metronidazole53$4,193
Clobetasol Propionate56$2,612
Ketoconazole149$2,192
Calcipotriene21$2,179
Azelaic Acid16$1,685
Fluocinonide33$1,541
Econazole Nitrate28$1,077
Doxycycline Hyclate43$1,007
Triamcinolone Acetonide98$996
Clindamycin Phosphate27$862
Alclometasone Dipropionate30$783
Hydrocortisone39$645
Ammonium Lactate27$577

Paid to pharmacies, not to this prescriber.

Other dermatology in Naperville

See the full list for Illinois →

Where these figures come from

Is this you, or does something look wrong? →